Patient leadership and partnerships accelerate therapies for SCN8A and other developmental and epileptic encephalopathies
{{output}}
Families are a driving force in accelerating the understanding and science of SCN8A. The urgency felt by families facing the absence of treatments for their children makes them uniquely positioned to advance therapies through advocacy, data sharing, and partne... ...